NOX3, a Superoxide-generating NADPH Oxidase of the Inner Ear
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) play a major role in drug-, noise-, and age-dependent hearing loss, but the source of ROS in the inner ear remains largely unknown. Herein, we demonstrate that NADPH oxidase (NOX) 3, a member of the NOX/dual domain oxidase family of NADPH oxidases, is highly expressed in specific portions of the inner ear. As assessed by real-time PCR, NOX3 mRNA expression in the inner ear is at least 50-fold higher than in any other tissues where its expression has been observed (e.g. fetal kidney, brain, skull). Microdissection and in situ hybridization studies demonstrated that NOX3 is localized to the vestibular and cochlear sensory epithelia and to the spiral ganglions. Transfection of human embryonic kidney 293 cells with NOX3 revealed that it generates low levels of ROS on its own but produces high levels of ROS upon co-expression with cytoplasmic NOX subunits. NOX3-dependent superoxide production required a stimulus in the absence of subunits and upon co-expression with phagocyte NADPH oxidase subunits p47(phox) and p67(phox), but it was stimulus-independent upon co-expression with colon NADPH oxidase subunits NOX organizer 1 and NOX activator 1. Pre-incubation of NOX3-transfected human embryonic kidney 293 cells with the ototoxic drug cisplatin markedly enhanced superoxide production, in both the presence and the absence of subunits. Our data suggest that NOX3 is a relevant source of ROS generation in the cochlear and vestibular systems and that NOX3-dependent ROS generation might contribute to hearing loss and balance problems in response to ototoxic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nox1, 3, 4, 5, and Duox1 and 2 usually produce smaller amounts of ROS for regulation of signaling pathways or during anabolic processes such as endothelial vasoregulation or synthesis of thyroid hormones [94,95,96,97,98].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [98]
Citations
Cites
Babior, B. M. (1999) · Blood · doi:10.1182/blood.v93.5.1464 · Cited by 2,134
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Babior, B. M., Lambeth, J. D., & Nauseef, W. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2642 · Cited by 911
Identification of Renox, an NAD(P)H oxidase in kidney
Geiszt, M., Kopp, J. B., Várnai, P., & Leto, T. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130135897 · Cited by 842
Homologs of gp91 phox : cloning and tissue expression of Nox3, Nox4, and Nox5
Cheng, G., Cao, Z., Xu, X., Meir, E. G. V., & Lambeth, J. D. (2001) · Gene · doi:10.1016/s0378-1119(01)00449-8 · Cited by 819
Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase Family
De Deken, X., Wang, D., Many, M.-C., Costagliola, S., Libert, F., Vassart, G., Dumont, J. E., & Miot, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000916200 · Cited by 638
A Ca2+-activated NADPH Oxidase in Testis, Spleen, and Lymph Nodes
Bánfi, B., Molnár, G., Maturana, A., Steger, K., Hegedûs, B., Demaurex, N., & Krause, K.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103034200 · Cited by 622
Self-citationA Novel Superoxide-producing NAD(P)H Oxidase in Kidney
Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., Hattori, M., Sakaki, Y., & Sumimoto, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007597200 · Cited by 517
Two Novel Proteins Activate Superoxide Generation by the NADPH Oxidase NOX1
Bánfi, B., Clark, R. A., Steger, K., & Krause, K.-H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200613200 · Cited by 491
Self-citationEarly Elevation of Cochlear Reactive Oxygen Species following Noise Exposure
Ohlemiller, K. K., Wright, J. S., & Dugan, L. L. (1999) · Audiology and Neurotology · doi:10.1159/000013846 · Cited by 436
Research works printed but not linked: 3
- Kopke, 1997, Am. J. Otol., 18, 559
- Darlington, 2003, Curr. Opin. Investig. Drugs., 4, 841
- Caillou, 2001, J. Clin. Endocrinol. Metab., 86, 3351
Cited by
Items 101–200 of 479
Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
Trendowski, M. R., Charif, O. E., Dinh, P. C., Travis, L. B., & Dolan, M. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2244 · Cited by 138
Oxidative Stress and Inflammation Caused by Cisplatin Ototoxicity
Ramkumar, V., Mukherjea, D., Dhukhwa, A., & Rybak, L. P. (2021) · Antioxidants · doi:10.3390/antiox10121919 · Cited by 143
“A key target of cisplatin in the cochlea is the NOX3 isoform of NADPH oxidase [22].”
BackgroundThe Contribution of Immune Infiltrates to Ototoxicity and Cochlear Hair Cell Loss
Wood, M. B., & Zuo, J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00106 · Cited by 137
NOX5: from basic biology to signaling and disease
Bedard, K., Jaquet, V., & Krause, K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.023 · Cited by 133
Self-citationWhich NADPH Oxidase Isoform Is Relevant for Ischemic Stroke? The Case for Nox 2
Kahles, T., & Brandes, R. P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4721 · Cited by 125
“Nox1, Nox2, Nox3, and Nox4 messenger ribonucleic acids (mRNAs) were detected in whole-brain extracts by PCR (10, 83), which obviously provides little information regarding functional significant protein levels.”
Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease
Burtenshaw, D., Kitching, M., Redmond, E. M., Megson, I. L., & Cahill, P. A. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00089 · Cited by 131
Du, Z., Yang, Y., Hu, Y., Sun, Y., Zhang, S., Peng, W., Zhong, Y., Huang, X., & Kong, W. (2012) · Hearing Research · doi:10.1016/j.heares.2012.04.012 · Cited by 131
“Scale bar: C, D ¼ 1 mm; A, B, EeH ¼ 0.5 mm. primary source of ROS generation in the cochlea, which contributes to cisplatin-induced ROS production in the cochlea (Banfi et al., 2004; Mukherjea et al., 2010a, b).”
InfluentialSmith, S. M. E., Min, J., Ganesh, T., Diebold, B., Kawahara, T., Zhu, Y., McCoy, J., Sun, A., Snyder, J. P., Fu, H., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.04.015 · Cited by 112
“Nox2 generates superoxide, as do Nox1, 3, and 5, while Nox4, Duox1 and Duox2 produce mainly hydrogen peroxide (Takac et al.,2011).”
BackgroundInfluentialPhysiological roles of NOX/NADPH oxidase, the superoxide-generating enzyme
Katsuyama, M., Matsuno, K., & Yabe-Nishimura, C. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-06sr · Cited by 116
NADPH oxidases in traumatic brain injury – Promising therapeutic targets?
Ma, M. W., Wang, J., Dhandapani, K. M., Wang, R., & Brann, D. W. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.005 · Cited by 117
The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses
Weyemi, U., & Dupuy, C. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.04.002 · Cited by 123
“This finding has since been amply confirmed [9–12]”
ResultNADPH oxidases: redox regulation of cell homeostasis and disease
Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 123
NADPH Oxidases in Lung Health and Disease
Bernard, K. F., Hecker, L., Luckhardt, T., Cheng, G., & Thannickal, V. J. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5608 · Cited by 114
“Nox3 is primarily expressed in the kidney and inner ear (13, 29), although it may be induced in the lung (186).”
BackgroundMutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice
Nakano, Y., Longo-Guess, C. M., Bergstrom, D. E., Nauseef, W. M., Jones, S. M., & Bánfi, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33835 · Cited by 108
Self-citationNovel p47 phox -Related Organizers Regulate Localized NADPH Oxidase 1 (Nox1) Activity
Gianni, D., Diaz, B., Taulet, N., Fowler, B., Courtneidge, S. A., & Bokoch, G. M. (2009) · Science Signaling · doi:10.1126/scisignal.2000370 · Cited by 109
“p47, p40, and NoxO1 serve as regulatory organizer subunits for the assembly and full activity of various Nox family members, including Nox2 (p47 and p40) (16, 38, 39) and Nox1 and Nox3 (NoxO1 and p47) (1, 12, 40, 41).”
BackgroundCahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 106
Mitochondria-Targeted Antioxidants for Treatment of Hearing Loss: A Systematic Review
Fujimoto, C., & Yamasoba, T. (2019) · Antioxidants · doi:10.3390/antiox8040109 · Cited by 115
Kaur, T., Borse, V., Sheth, S., Sheehan, K. E., Ghosh, S., Tupal, S., Jajoo, S., Mukherjea, D., Rybak, L. P., & Ramkumar, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3111-15.2016 · Cited by 109
“A1AR activation reduces ROS generation via NOX3 Cisplatin ototoxicity is mediated in part by ROS produced via NOX3 (Bánfi et al., 2004; Mukherjea et al., 2008).”
BackgroundProgress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss
Hazlitt, R. A., Min, J., & Zuo, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01653 · Cited by 108
Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells
Kim, S.-J., Park, C., Han, A. L., Youn, M., Lee, J.-H., Kim, Y., Kim, E.-S., Kim, H., Kim, J.-K., Lee, H.-K., et al. (2009) · Hearing Research · doi:10.1016/j.heares.2009.03.003 · Cited by 108
Reactive oxygen species and NADPH oxidase 4 involvement in osteoarthritis
Drevet, S., Gavazzi, G., Grange, L., Dupuy, C., & Lardy, B. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.007 · Cited by 112
Katsuyama, M. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r01cr · Cited by 103
Downstream Targets and Intracellular Compartmentalization in Nox Signaling
Chen, K., Craige, S. E., & Keaney, J. F. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2594 · Cited by 102
“References: Nox1 (2, 4, 6, 27, 59, 65, 104, 107), Nox2 (15, 39, 46, 68, 84, 105, 108), Nox 3 (5, 111, 112), Nox 4 (20, 26, 35, 45, 50, 90, 114, 125), Nox 5 (7, 8, 23), Duox 1=2 (28, 36, 38).”
Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase
Zhang, Q., Malik, P., Pandey, D., Gupta, S., Jagnandan, D., de Chantemele, E. B., Banfi, B., Marrero, M. B., Rudic, R. D., Stepp, D. W., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168278 · Cited by 107
Self-citationZhang, X., Krause, K.-H., Xenarios, I., Soldati, T., & Boeckmann, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058126 · Cited by 109
“NOX3 human: Q9HBY0, mouse: Q672J9 Signaling and/or biosynthesis in the inner ear (otoconia formation) [79,80]”
BackgroundSelf-citationRokutan, K., Kawahara, T., Kuwano, Y., Tominaga, K., Sekiyama, A., & Teshima-Kondo, S. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1573 · Cited by 114
Hughes, I., Thalmann, I., Thalmann, R., & Ornitz, D. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.074 · Cited by 110
“The het phenotype results from a recessive mutation within the gene encoding NADPH-Oxidase 3 (NOX3), a reactive oxygen species generating oxidase specific to the inner ear (Banfi et al., 2004; Paffenholz et al., 2004).”
BackgroundNADPH oxidases and the evolution of plant salinity tolerance
Liu, M., Yu, H., Ouyang, B., Shi, C., Demidchik, V. V., Hao, Z., Yu, M., & Shabala, S. N. (2020) · Plant Cell & Environment · doi:10.1111/pce.13907 · Cited by 111
NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 99
Assembly of the otoconia complex to the macular sensory epithelium of the vestibule
Lundberg, Y. W., Zhao, X., & Yamoah, E. N. (2006) · Brain Research · doi:10.1016/j.brainres.2006.02.083 · Cited by 101
Inactivation of NADPH oxidase organizer 1 Results in Severe Imbalance
Kiss, P. J., Knisz, J., Zhang, Y., Baltrušaitis, J., Sigmund, C. D., Thalmann, R., Smith, R. J., Verpy, E., & Bánfi, B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.025 · Cited by 108
Self-citationCurrent Strategies to Combat Cisplatin-Induced Ototoxicity
Yu, D., Gu, J., Chen, Y., Kang, W., Wang, X., & Wu, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00999 · Cited by 100
“, fetal kidney, brain, skull) is strongly induced by cisplatin (Banfi et al., 2004; Karasawa and Steyger, 2015).”
BackgroundTemkin, V., & Karin, M. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00560.x · Cited by 96
“cytosolic proteins such as NADPH oxidase organizer 1 (NOXO1), an isoform of p47 (70) and Rac1 (71).”
BackgroundNitric Oxide, NAD(P)H Oxidase, and Atherosclerosis
Muller, G., & Morawietz, H. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2403 · Cited by 97
Nox4 as a novel therapeutic target for diabetic vascular complications
Wang, D., Li, J., Luo, G., Zhou, J., Wang, N., Wang, S., Zhao, R., Cao, X., Ma, Y., Liu, G., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102781 · Cited by 100
Mukherjea, D., Jajoo, S., Sheehan, K. E., Kaur, T., Sheth, S., Bunch, J. R., Perro, C. A., Rybak, L. P., & Ramkumar, V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3497 · Cited by 98
“NOX3 represents the primary source of ROS generation in the cochlea, which contributes to cisplatin-induced ROS production in the cochlea (2, 23).”
BackgroundNADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin
Tirone, F., & Cox, J. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.047 · Cited by 93
“NOX3, expressed in vestibular and cochlear epithelia of the inner ear [7], is fully”
BackgroundMolecular evolution of Phox-related regulatory subunits for NADPH oxidase enzymes
Kawahara, T., & Lambeth, J. D. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-178 · Cited by 93
“Like Nox1, Nox3 is also regulated by p22phox and NOXO1, but in humans does not require NOXA1 [48-51].”
BackgroundNOX enzymes and Toll-like receptor signaling
Ogier‐Denis, É., Mkaddem, S. B., & Vandewalle, A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0120-9 · Cited by 96
“NOX3 is expressed in the inner ear and is involved in otoconia formation [12].”
Reactive Oxygen Species: Not Omnipresent but Important in Many Locations
Herb, M., Gluschko, A., & Schramm, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716406 · Cited by 87
von Leden, R. E., Yauger, Y. J., Khayrullina, G., & Byrnes, K. R. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4486 · Cited by 90
“Initially it was only identified within the vestibular apparatus of the inner ear, and is essential for proper development.(62) NOX3 has been located in other cell types, including neurons.”
Critical roles for p22 phox in the structural maturation and subcellular targeting of Nox3
Nakano, Y., Banfi, B., Jesaitis, A. J., Dinauer, M. C., Allen, L.-A. H., & Nauseef, W. M. (2007) · Biochemical Journal · doi:10.1042/bj20060819 · Cited by 86
Self-citationThe NADPH Oxidase Family and Its Inhibitors
Chocry, M., & Leloup, L. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7915 · Cited by 96
“It has been found mainly in the inner ear and more particularly in the vestibular and auditory system (15).”
Role of the small GTPase Rac in p22 -dependent NADPH oxidases
Miyano, K., & Sumimoto, H. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.003 · Cited by 94
Nauseef, W. M. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0117-4 · Cited by 93
Novel sources of reactive oxygen species in the human body
Orient, A., Donkó, Á., Szabo, A. J., Leto, T. L., & Geiszt, M. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm077 · Cited by 103
“Data obtained from experiments with transfected cell lines suggest that Nox3 is able to produce low amounts of superoxide in the absence of cytosolic regulators [14]; however, its enzymatic activity is effectively stimulated by p47 and p67 [14,23,24].”
BackgroundThe small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity
Velaithan, R., Kang, J., Hirpara, J. L., Loh, T. K. S., Goh, B. C., Bras, M. L., Brenner, C., Clement, M., & Pervaiz, S. (2011) · Blood · doi:10.1182/blood-2010-08-301283 · Cited by 89
NADPH Oxidase-Mediated Oxidative Stress: Genetic Studies of the p22 phox Gene in Hypertension
Zalba, G., José, G. S., Moreno, M. U., Fortuño, A., & Díez, J. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1327 · Cited by 85
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Weyemi, U., Redon, C. E., Parekh, P. R., Dupuy, C., & Bonner, W. M. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520611313030013 · Cited by 95
“NOX3 has been shown to be expressed in rat inner ear and primarily in human fetal tissues [24, 56] and may have a role in organogenesis [57].”
BackgroundReduced expression of the NADPH oxidase NOX4 is a hallmark of adipocyte differentiation
Mouche, S., Mkaddem, S. B., Wang, W., Katic, M., Tseng, Y.-H., Carnesecchi, S., Steger, K., Foti, M., Meier, C. A., Muzzin, P., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.03.003 · Cited by 81
Self-citationRoot phonotropism: Early signalling events following sound perception in Arabidopsis roots
Rodrigo-Moreno, A., Bazihizina, N., Azzarello, E., Masi, E., Tran, D., Bouteau, F., Baluška, F., & Mancuso, S. (2017) · Plant Science · doi:10.1016/j.plantsci.2017.08.001 · Cited by 83
Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin
Mukherjea, D., Whitworth, C. A., Nandish, S., Dunaway, G., Rybak, L. P., & Ramkumar, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.044 · Cited by 83
Inhibiting the Activity of NADPH Oxidase in Cancer
Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 87
“NOX1 Colon epithelium (166) Colorectal adenocarcinoma (14, 33, 39, 95, 119, 169) NOX2 Phagocytes (17) Hematopoietic and lymphoid cancers (1, 13, 85, 125) NOX3 Inner ear (18) N/A NOX4 Kidney, endothelial cells (75, 103, 159) Kidney, ovary, brain, and bladder cancer; melanoma (103, 129, 159, 160) NOX5 Spleen, testis, an…”
BackgroundRegulation of Novel Superoxide-Producing NAD(P)H Oxidases
Takeya, R., & Sumimoto, H. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1523 · Cited by 79
Lavinsky, J., Crow, A. L., Pan, C., Wang, J., Aaron, K. A., Ho, M. K., Li, Q., Salehide, P., Myint, A., Monges-Hernadez, M., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005094 · Cited by 89
“Of note, Nox3, the gene in which our peak GWAS SNP is located, does not have an eQTL in the cochlea; however, there was a clear demonstration [23] that Nox3 is highly expressed (at least 50-fold higher than in any other tissues) in specific portions of the inner ear.”
BackgroundInfluentialOtotoxic drugs: Difference in sensitivity between mice and guinea pigs
Poirrier, A., den Ackerveken, P. V., Kim, T. S., Vandenbosch, R., Nguyen, L., Lefebvre, P. P., & Malgrange, B. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.12.003 · Cited by 81
“Evidence for direct cisplatin-induced neuronal toxicity has also been reported (Banfi et al., 2004; van Ruijven et al., 2004).”
BackgroundSelf-citationIsoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U. G., & Schmidt, H. H. H. W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.038 · Cited by 85
Pharmacology of apocynin: a natural acetophenone
Savla, S. R., Laddha, A. P., & Kulkarni, Y. A. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1895203 · Cited by 81
“The wide expression of NOX 4 was found in the endoplasmic reticulum and perinuclear space of endothelial cells (B anfi et al. 2004).”
BackgroundMechanisms of cisplatin ototoxicity: theoretical review
Gonçalves, M. S., da Silveira, A. F., Teixeira, A. R., & Hyppolito, M. Â. (2013) · The Journal of Laryngology & Otology · doi:10.1017/s0022215113000947 · Cited by 80
Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders
Kishimoto‐Urata, M., Urata, S., Fujimoto, C., & Yamasoba, T. (2022) · Antioxidants · doi:10.3390/antiox11081469 · Cited by 93
“The cochlear sensory epithelium and ROS-producing enzymes NADPH oxidase 3 (NOX3) [51,52] and xanthine oxidase [53] are expressed in spiral ganglion cells.”
BackgroundLactate Regulates Rat Male Germ Cell Function through Reactive Oxygen Species
Galardo, M. N., Regueira, M., Riera, M. F., Pellizzari, E. H., Cigorraga, S. B., & Meroni, S. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088024 · Cited by 78
“NOX3 is only expressed in the inner ear [41].”
BackgroundStasia, M. J. (2016) · Gene · doi:10.1016/j.gene.2016.03.050 · Cited by 80
“This was demonstrated by the functional impact of NOX3 mutations in head-tilt mice with vestibular defects (Banfi et al., 2004; Paffenholz et al., 2004; Nakano et al., 2007).”
BackgroundLinks between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 80
The Role of Reactive Oxygen Species in Microvascular Remodeling
Staiculescu, M. C., Foote, C. A., Meininger, G. A., & Martinez‐Lemus, L. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151223792 · Cited by 82
“Nox3 is found almost exclusively in the inner ear [47].”
BackgroundTateishi, Y., Sasabe, E., Ueta, E., & Yamamoto, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.039 · Cited by 75
“There have been a few studies on the expression of Nox family mRNAs and proteins in different kinds of human cells [15-21], but very few studies on the expression of Nox1 to Nox5 in the salivary glands even though it has been reported that salivary gland ducts express Duox1 [27].”
BackgroundOpportunity Nox: The Future of NADPH Oxidases as Therapeutic Targets in Cardiovascular Disease
Streeter, J., Thiel, W. H., Brieger, K., & Miller, F. J. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2011.00310.x · Cited by 76
Traumatic Noise Activates Rho-Family GTPases through Transient Cellular Energy Depletion
Chen, F., Zheng, H., Hill, K., & Sha, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6381-11.2012 · Cited by 77
“Additionally, the amount of Nox3 in cochlear homogenates was investigated because Nox3 has been reported as an NADPH subunit localized to the sensory epithelia of the inner ear (Bánfi et al., 2004).”
BackgroundOrganizers and activators: Cytosolic Nox proteins impacting on vascular function
Schröder, K., Weißmann, N., & Brandes, R. P. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.017 · Cited by 81
The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis
Prieto-Bermejo, R., & Hernández‐Hernández, Á. (2017) · Antioxidants · doi:10.3390/antiox6020032 · Cited by 77
“Like Nox2, Nox1 is also associated with p22phox [49] and requires other cytosolic subunits for its activity, such as NOXO1 (NOX organizer 1, a homologue of p47phox), NOXA1 (NOX activator 1, a homologue of p67phox), and the Rac GTPase [60].”
BackgroundInfluentialRole of Nadph Oxidase in Atherosclerosis
Violi, F., Basili, S., Nigro, C., & Pignatelli, P. (2009) · Future Cardiology · doi:10.2217/14796678.5.1.83 · Cited by 73
“25, 1452–1457 (2005).”
InfluentialRedox Circuitries Driving Src Regulation
Giannoni, E., & Chiarugi, P. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5525 · Cited by 69
“NOX1 and NOX3 are highly expressed in epithelium, endothelium, smooth muscles, fibroblasts, microglia, or the inner ear (5) and require the subunits mentioned earlier for full activation; instead, Rac-1 plays the key regulatory role connecting these oxidases to the generation of ROS by…”
Reactive Oxygen Species Derived from NOX3 and NOX5 Drive Differentiation of Human Oligodendrocytes
Accetta, R., Damiano, S., Morano, A., Mondola, P., Paternò, R., Avvedimento, E. V., & Santillo, M. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00146 · Cited by 77
“As to NOX3, this enzyme is highly expressed in vestibular and cochlear sensory epithelia and in the spiral ganglion in the inner ear (Bánfi et al., 2004) and its activity has been linked to deafness and to the ototoxicity of drugs and toxins (Mukherjea et al.”
BackgroundMartínez‐Vega, R., Garrido, F., Partearroyo, T., Cediel, R., Zeisel, S. H., Martínez‐Álvarez, C., Varela‐Moreiras, G., Varela‐Nieto, I., & Pajares, M. A. (2014) · The FASEB Journal · doi:10.1096/fj.14-259283 · Cited by 71
“NOX activator subunits, such as p22phox, are the main proteins involved in stress response (63, 64).”
BackgroundOxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited
Gabrielli, A., Svegliati, S., Moroncini, G., Pomponio, G., Santillo, M., & Avvedimento, E. V. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0125-4 · Cited by 71
NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone
Frazziano, G., Champion, H. C., & Pagano, P. J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00780.2011 · Cited by 75
“Nox3 is principally expressed in the inner ear and less notably in fetal brain and kidney tissues (14) and seems to generate low levels of O2 in a cytosolic subunit-independent manner and high levels of O2 in the presence of activator and organizer subunits (p47 and p67, NOXO1 and NOXA1) (14).”
BackgroundInfluentialYoshida, L. S., & Tsunawaki, S. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.05.004 · Cited by 68
NOX Inhibitors: From Bench to Naxibs to Bedside
Elbatreek, M. H., Mucke, H. A., & Schmidt, H. H. H. W. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_387 · Cited by 72
The role of NADPH oxidases in neuronal development
Terzi, A., & Suter, D. M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.04.027 · Cited by 69
Du, Z., Yang, Q., Liu, L., Li, S., Zhao, J., Hu, J., Liu, C. H., Qian, D., & Gao, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.061 · Cited by 69
“The previous studies have demonstrated that NOX3 represents the primary source of ROS generation in the cochlea, which contributes to cisplatininduced ROS production in the cochlea, while knockdown of NOX3 by siRNA can reduce NOX3-dependent ROS generation and against cisplatin-induced ototoxicity (Banfi et al., 2004;…”
Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer
Romano, A., Capozza, M. A., Mastrangelo, S., Maurizi, P., Triarico, S., Rolesi, R., Attinà, G., Fetoni, A. R., & Ruggiero, A. (2020) · Cancers · doi:10.3390/cancers12051266 · Cited by 65
Paletta-Silva, R., Rocco-Machado, N., & Meyer‐Fernandes, J. R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023683 · Cited by 77
Opitz, N., Drummond, G. R., Selemidis, S., Meurer, S., & Schmidt, H. H. H. W. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.003 · Cited by 66
Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors
Lee, S. R., An, E. J., Kim, J., & Bae, Y. S. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2019.188 · Cited by 69
Protective Effect of Metformin Against Cisplatin-Induced Ototoxicity in an Auditory Cell Line
Chang, J., Jung, H. H., Yang, J. Y., Lee, S., Choi, J., Im, G. J., & Chae, S. W. (2013) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-013-0431-y · Cited by 65
“These interactions generate reactive oxygen species (ROS) (Clerici et al. 1995; Dehne et al. 2001; Banfi et al. 2004) while depleting the antioxidant enzyme system that would scavenge and neutralize this increase in superoxides (Rybak et al. 2000) The cochlea, because of its unique anatomical…”
BackgroundMiyata, Y., Matsuo, T., Sagara, Y., Ohba, K., Ohyama, K., & Sakai, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102214 · Cited by 64
“NOX3 is expressed in the inner ear [56].”
BackgroundNOX2-Derived Reactive Oxygen Species in Cancer
Wiktorin, H. G., Aydin, E., Hellstrand, K., & Martner, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7095902 · Cited by 66
Cheng, G., & Lambeth, J. D. (2005) · Gene · doi:10.1016/j.gene.2005.03.008 · Cited by 69
Subcellular localization and function of alternatively spliced Noxo1 isoforms
Ueyama, T., Lekstrom, K. J., Tsujibe, S., Saito, N., & Leto, T. L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.024 · Cited by 65
“Noxo1, Noxa1, and Rac1 also support Nox3 activity, which appears to function critically in the inner ear [17,20-22]; mice with lesions in either the NOX3 or NOXO1 gene have defects in sensing gravity resulting from impaired otoconia formation [23,24].”
Gentamicin Rapidly Inhibits Mitochondrial Metabolism in High-Frequency Cochlear Outer Hair Cells
Jensen‐Smith, H. C., Hallworth, R., & Nichols, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038471 · Cited by 65
“Notably, the NOX family of NADPH oxidases is another recognized source of ROS in cochlear HCs [58–60].”
BackgroundAntony, S., Wu, Y., Hewitt, S. M., Anver, M. R., Butcher, D., Jiang, G., Meitzler, J. L., Liu, H., Juhasz, A., Lu, J., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.005 · Cited by 57
Adenosine and the Auditory System
Vlajkovic, S. M., Housley, G. D., & Thorne, P. R. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152155 · Cited by 62
“Cisplatin induces ROS generation in cochlear tissues and upregulation of the NOX3 isoform of NADPH oxidase [6].”
BackgroundMcCann, S., & Roulston, C. L. (2013) · Brain Sciences · doi:10.3390/brainsci3020561 · Cited by 68
ROS-Generating Oxidase Nox3 Regulates the Self-Renewal of Mouse Spermatogonial Stem Cells1
Morimoto, H., Kanatsu‐Shinohara, M., & Shinohara, T. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.127647 · Cited by 59
Intratympanic Dexamethasone to Prevent Cisplatin Ototoxicity: A Guinea Pig Model
Murphy, D. M., & Daniel, S. J. (2011) · Otolaryngology · doi:10.1177/0194599811406673 · Cited by 59
“This leads to an increase in free radicals and inflammatory molecules causing DNA damage, lipid peroxidation, and eventual cell death.(6,8,9) To date, there is no treatment against cisplatin-induced ototoxicity.”
BackgroundNADPH Oxidases as Novel Pharmacologic Targets against Influenza A Virus Infection
Vlahos, R., & Selemidis, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095216 · Cited by 61
Otoconin-90 deletion leads to imbalance but normal hearing: A comparison with other otoconia mutants
Zhao, X., Jones, S. M., Yamoah, E. N., & Lundberg, Y. W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.055 · Cited by 57
“, 2008), but Nox3 is also expressed in the sensory epithelium at adult stages (Banfi et al., 2004).”
InfluentialBekeschus, S., Liebelt, G., Menz, J., Berner, J., Sagwal, S. K., Wende, K., Weltmann, K., Boeckmann, L., von Woedtke, T., Metelmann, H., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.035 · Cited by 56
Molecular regulation of NADPH oxidase 5 via the MAPK pathway
Pandey, D., & Fulton, D. J. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01163.2010 · Cited by 55
Noise-induced changes in expression levels of NADPH oxidases in the cochlea
Vlajkovic, S. M., Lin, S. C. Y., Wong, A. C. Y., Wackrow, B., & Thorne, P. R. (2013) · Hearing Research · doi:10.1016/j.heares.2013.07.012 · Cited by 61
“NOX3 was not immunolocalised in the spiral ganglion neurones of the rat cochlea, which is in contrast to previously published study showing NOX3 expression in the mouse spiral ganglion using in situ hybridisation (Banfi et al., 2004).”
BackgroundResultInfluentialNox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Cifuentes-Pagano, M., Meijles, D., & Pagano, P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112013 · Cited by 55
Metadata
- Authors
- Bánfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., & Krause, K.-H.
- Affiliations
- University of Iowa (US)
- University of Liège (BE)
- Justus-Liebig-Universität Gießen (DE)
- University Hospital of Geneva (CH)
- Corresponding author
- Bánfi, Botond
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 279
- Issue
- 44
- Pages
- 46065-46072
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2057397798
- Cited by
- 467
- References
- 41
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 21 · 2023: 26 · 2022: 14 · 2021: 25 · 2020: 24 · 2019: 24 · 2018: 22 · 2017: 17 · 2016: 22 · 2015: 24 · 2014: 22 · 2013: 21 · 2012: 31
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5832 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion)
- Funders
- Louis-Jeantet Foundation
- National Institutes of Health (AI-20866)
- U.S. Public Health Service
- National Institute on Aging (R01AG019519, AG19519-01)
- National Institute of Allergy and Infectious Diseases (AI20866-18, R01AI020866)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- NOX3, NADPH oxidase, superoxide production, reactive oxygen species, inner ear, cochlea, vestibular sensory epithelium, spiral ganglion, cisplatin ototoxicity, p47phox, p67phox, hearing loss, balance disorders, gene expression
- MeSH terms
- NADPH Oxidase 2, Animals, Base Sequence, Cells, Cultured, Humans, Ear, Inner, Membrane Glycoproteins, Mice, Inbred C57BL, Molecular Sequence Data, Proteins, RNA, Messenger, Superoxides, Rats, Sprague-Dawley, In Situ Hybridization, DNA, Complementary, NADPH Oxidases, Protein Subunits, Adaptor Proteins, Signal Transducing, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.